Construct: ORF ccsbBroadEn_10954
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF000651.1_s300c1, BRDN0000394725
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- LY9 (4063)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_017001304.1 | 78.3% | 75.7% | (many diffs) |
| 2 | human | 4063 | LY9 | lymphocyte antigen 9 | NM_001261457.2 | 71.5% | 71.3% | (many diffs) |
| 3 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_011509556.1 | 66% | 65.8% | (many diffs) |
| 4 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_011509560.1 | 63.7% | 63.5% | (many diffs) |
| 5 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_017001302.1 | 63.6% | 61.6% | (many diffs) |
| 6 | human | 4063 | LY9 | lymphocyte antigen 9 | NM_002348.4 | 61.6% | 61.5% | (many diffs) |
| 7 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_017001303.1 | 61.4% | 59.3% | (many diffs) |
| 8 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_017001301.1 | 59.5% | 57.6% | (many diffs) |
| 9 | human | 4063 | LY9 | lymphocyte antigen 9 | NM_001261456.2 | 59.5% | 59.3% | (many diffs) |
| 10 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_017001300.1 | 58.3% | 56.4% | (many diffs) |
| 11 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_011509549.1 | 57.5% | 57.4% | (many diffs) |
| 12 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_011509548.1 | 57.4% | 57.3% | (many diffs) |
| 13 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_017001297.1 | 55.6% | 53.8% | (many diffs) |
| 14 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_017001299.1 | 55.5% | 55.4% | (many diffs) |
| 15 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_011509550.1 | 54.4% | 54.6% | (many diffs) |
| 16 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_011509552.1 | 54.2% | 54.1% | (many diffs) |
| 17 | human | 4063 | LY9 | lymphocyte antigen 9 | XM_017001298.1 | 53.6% | 51.8% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 69
- ORF end:
- 1284
- ORF length:
- 1215
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaacttTG TACAAAAAAG 61 TTGGCACCAT GAAGTCTGTG AAGGTGTCTG AGAACTTCTC CTGTAACATC ACTCTAATGT 121 GCTCCGTGAA GGGGGCAGAG AAAAGTGTTC TGTACAGCTG GACCCCAAGG GAACCCCATG 181 CTTCTGAGTC CAATGGAGGC TCCATTCTTA CCGTCTCCGG AACACCATGT GACCCAGACC 241 TGCCATACAT CTGCACAGCC CAGAACCCCG TCAGCCAGAG AAGCTCCCTC CCTGTCCATG 301 TTGGGCAGTT CTGTACAGAT CCAGGAGCCT CCAGAGGAGG AACAACGGGG GAGACTGTGG 361 TAGGGGTCCT GGGAGAGCCA GTCACCCTGC CACTTGCACT CCCAGCCTGC CGGGACACAG 421 AGAAGGTTGT CTGGTTGTTT AACACATCCA TCATTAGCAA AGAGAGGGAA GAAGCAGCAA 481 CGGCAGATCC ACTCATTAAA TCCAGGGATC CTTACAAGAA CAGGGTGTGG GTCTCCAGCC 541 AGGACTGCTC CCTGAAGATC AGCCAGCTGA AGATAGAGGA CGCCGGCCCC TACCATGCCT 601 ACGTGTGCTC AGAGGCCTCC AGCGTCACCA GCATGACACA TGTCACCCTG CTCATCTACC 661 GACCTGAGAG AAACACAAAG CTTTGGATTG GGTTGTTCCT GATGGTTTGC CTTCTGTGCG 721 TTGGGATCTT CAGCTGGTGC ATTTGGAAGC GAAAAGGACG GTGTTCAGTC CCAGCCTTCT 781 GTTCCAGCCA AGCTGAGGCC CCAGCGGATA CACCAGAACC CACAGCTGGC CACACGCTAT 841 ACTCTGTGCT CTCCCAAGGA TATGAGAAGC TGGACACTCC CCTCAGGCCT GCCAGGCAAC 901 AGCCTACACC CACCTCAGAC AGCAGCTCTG ACAGCAACCT CACAACTGAG GAGGATGAGG 961 ACAGGCCTGA GGTGCACAAG CCCATCAGTG GAAGATATGA GGTGTTTGAC CAGGTCACTC 1021 AGGAGGGCGC TGGACATGAC CCAGCCCCTG AGGGCCAAGC AGACTATGAT CCCGTCACTC 1081 CATATGTCAC GGAAGTTGAG TCTGTGGTTG GAGAGAACAC CGTGTATGCA CAAGTGTTCA 1141 ACTTACAGGG AAAGACCCCA GTTTCTCAGA AGGAAGAGAG CTCAGCCACA ATCTACTGCT 1201 CCATACGGAA ACCTCAGGTG GTGCCACCAC CACAACAGAA TGATCTTGAG ATTCCTGAAA 1261 GTCCTACCTA TGAAAATTTC ACCTTGCCAA CTTTCTTGTA CAAAGTtggc attataagaa 1321 agcattgctt atcaatttgt tgcaacgaac